Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004490923 | SCV004990677 | uncertain significance | not specified | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.1565T>G (p.F522C) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a T to G substitution at nucleotide position 1565, causing the phenylalanine (F) at amino acid position 522 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |